-transparent.png){kind=logo}
Few guidelines exist for judging the efficacy of antiarrhythmic drugs in patients with supraventricular arrhythmias. Useful definitions concerning the frequency and duration of supraventricular arrhythmias are offered, and complete and partial efficacy criteria are outlined for noninvasive electrocardiographic and invasive electrophysiologic techniques. Several open label, double-blind, parallel and crossover study designs are suggested for efficacy studies concerning the termination and prevention of supraventricular tachycardia. These recommendations are useful for designing new drug trials needed to evaluate properly the efficacy of antiarrhythmic agents in the treatment of various supraventricular arrhythmias.
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
June 1990,
Cardiovascular drugs and therapy,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
November 1984,
The American journal of cardiology,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
February 1985,
Clinical pharmacology and therapeutics,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
May 1986,
Cardiology clinics,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
January 1983,
Giornale italiano di cardiologia,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
April 1989,
Revista medica de Chile,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
June 1990,
Cardiovascular drugs and therapy,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
July 1991,
Pacing and clinical electrophysiology : PACE,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
January 1992,
Journal of cardiovascular pharmacology,
G V Naccarelli, and
A H Dougherty, and
E Berns, and
R L Rinkenberger
September 1979,
Annals of internal medicine,
